COMPOUND WITH CONFIDENCE: PCCA Membership, $895/month.

Pharmacy compounding's source for clinical information, regulatory updates, and opportunities

THE PCCA BLOG

rss

Stay current on PCCA news and events, market trends, and all things compounding!

Oral_vs_Topical_Estrogen_What_the_Literature_Is_Showing_about_Health_Risk_Part_One.png

Compounded bioidentical hormone replacement therapy (BHRT) is an important treatment option for women around the world. Colleagues and patients alike come to PCCA experts Pamela Smith, Nat Jones and Sara Hover for guidance. In this article, our three experts cover this all-too-important topic in the HRT conversation, on what current literature says about the usage of oral vs. topical estrogen discussion.

A_New_Anhydrous_Base_for_Female_Hormone_Delivery.png

PCCA launches an exciting new base at their 2019 International Seminar. Click here to learn all about it.

201904_ThePCCABlog_VersaBase_1768x500.png

Compounding pharmacies have been using PCCA's VersaBase Cream for years. Today, we'd like to talk to you about VersaBase's incredible ability to assist in women's Hormone Replacement Therapy.

201902_ThePCCABlog_Tadalafil_1768x500.png

Tadalafil is now free of patents, and compounding pharmacies have some opportunities to use this drug in various customized medications. PCCA's Nat Jones drops in to tell us why that is such exciting news for compounding pharmacies and their patients.

201902_ThePCCABlog_Oxytocin_1768x500.png

Devaki Lindsey Berkson, a well-respected nutritionist and hormone research expert, and what she has to say might just change the way you think about the "cuddle chemical"--Oxytocin.

201901_ThePCCABlog_MetforminForHirsutism_1768x500.png

Sara Hover, RPh, FAARM, is a Clinical Compounding Pharmacist at PCCA and she has exciting news about a treatment option for women diagnosed with Hirsutism.